肿瘤微环境特征揭示了新辅助免疫化疗在可切除非小细胞肺癌中优于化疗的原因
Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung canc
IO+化疗诱导的主要病理缓解(MPR)显著更高(75.0% vs.
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung canc
IO+化疗诱导的主要病理缓解(MPR)显著更高(75.0% vs.
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.
基于RNA测序数据,在197例患者中建立了转录组免疫模式。
CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders.
尽管 CD20 最初被鉴定为 B 细胞特异性标志物,但其在记忆 T 细胞上的表达拓展了我们对该分子分布和功能的认识。
Microenvironmental Changes in Mediastinal Fat-associated Lymphoid Clusters and Lungs in Early and Late Stages of Metastatic Lung Cancer Induction.
我们的发现提示了一种通过靶向MFALCs中免疫细胞的有前景的癌症治疗策略。
MEMBER ACCOUNT
登录成功会直接打开下一页。